{"nct_id":"NCT04680052","title":"A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2021-04-15","start_date_type":"ACTUAL","primary_completion_date":"2024-02-23","primary_completion_date_type":"ACTUAL","completion_date":"2028-08-09","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["INCY"]}